Boston Scientific (BSX) Change in Receivables (2020 - 2026)
Boston Scientific (BSX) posted quarterly Change in Receivables of $46.0 million for Q2 2026, up 43.75% year-over-year from $32.0 million in Q2 2025, and down 60.68% on a QoQ basis from $117.0 million in Q1 2026.
Boston Scientific (BSX) Change in Receivables (2020 - 2026) Analysis & Trends
Boston Scientific has reported Change in Receivables for 7 years, with the latest figure at $46.0 million in Q2 2026.
- Change in Receivables for Q2 2026 came in at $46.0 million, up 43.75% year-over-year; the trailing twelve-month figure through Jun 2026 was $293.0 million (up 11.83% YoY), and the FY2025 annual result was $269.0 million, down 23.36% from the prior year.
- Change in Receivables retreated to $46.0 million in Q2 2026, from $117.0 million in the prior quarter.
- Over five years, Change in Receivables peaked at $117.0 million in Q1 2026 and troughed at $3.0 million in Q3 2023.
- A 5-year average of $68.9 million and a median of $74.5 million in 2023 frame the typical range for Change in Receivables.
- The widest annual swing landed in 2023, when Change in Receivables slumped 78.57%; it then jumped 1000.0% in 2024.
- A 5-year view of Change in Receivables shows it stood at $44.0 million in 2022, then soared by 68.18% to $74.0 million in 2023, then gained by 21.62% to $90.0 million in 2024, then increased by 8.89% to $98.0 million in 2025, then slumped by 53.06% to $46.0 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $46.0 million in Q2 2026, $117.0 million in Q1 2026, and $98.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | 38.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.00 Mn |
| Jun 30, 2026 | 46.00 Mn |
| Mar 31, 2026 | 117.00 Mn |
| Mar 31, 2026 | 117.00 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Sep 30, 2025 | 32.00 Mn |
| Sep 30, 2025 | 32.00 Mn |
| Jun 30, 2025 | 32.00 Mn |
| Jun 30, 2025 | 32.00 Mn |
| Mar 31, 2025 | 107.00 Mn |
| Mar 31, 2025 | 107.00 Mn |
| Dec 31, 2024 | 90.00 Mn |
| Dec 31, 2024 | 90.00 Mn |
| Sep 30, 2024 | 33.00 Mn |
| Sep 30, 2024 | 33.00 Mn |
| Jun 30, 2024 | 114.00 Mn |
| Jun 30, 2024 | 114.00 Mn |
| Mar 31, 2024 | 114.00 Mn |
| Mar 31, 2024 | 114.00 Mn |